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Abstract

Objective: The objective of this systematic review is to determine whether Kangaroo Care is
effective in reducing procedural pain in neonates.
Study Design: Review of three English language single-blind randomized, controlled trials from
2008.
Data Sources: Randomized, single-blind control trials comparing Kangaroo Care to standard
Incubator Care as analgesia for neonates during routine medical procedures. All studies were
located using the OVID, Medline, and Cochrane databases.
Outcomes Measured: Neonate pain to minimally invasive routine medical procedures including
vitamin K injection and heel stick. Neonate pain includes parameters of both audible and
inaudible crying. All three of the studies utilized standardized scoring systems to rate facial cues
and behavioral indicators of neonate pain and distress. These scoring systems include the
Andersen Behavioral State Scoring System, the Neonatal Infant Pain Scale, and the Premature
Infant Pain Profile.
Results: Mean crying times and facial indicators of distress were significantly decreased in
neonates receiving Kangaroo Care versus the standard Incubator Care. No adverse events or
effects were reported from implementation of the KC intervention.
Conclusion: All of the studies reviewed demonstrate that Kangaroo Care is effective in reducing
neonate pain and distress during routine minimally invasive medical procedures. Further research
is needed to determine the optimal amount of Kangaroo Care time needed for individual
procedures. Likewise, further research should examine paternal and/or surrogate caregivers as
the bonding partner. The easy availability, cost effectiveness, and natural bonding of Kangaroo
Care make it a promising addition to the nonpharmacologic interventions available for
alleviating neonate pain and distress.
Key Words: Kangaroo Care, Skin to Skin Contact, pain, infant, neonate
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Introduction
Neonates undergo multiple stressors from the time of birth to discharge from the hospital
setting. Most of these processes-APGAR scoring, heel sticks, vitamin K injections and the like
are required to ensure the health of a newborn or to determine cause of current or future illness.
The pain and distress experienced by the neonate and by proxy the caregivers from such
procedures make it desirable to have an arsenal of both pharmacologic and nonpharmacologic
interventions available to minimize this distress; especially for those procedures that are invasive
in nature such as venipuncture and injections.
Currently, many of the aforementioned procedures are performed while the neonate is
within the confines of an incubator. Incubator care (IC) is therefore the current standard for early
observation of the neonate as incubators are well equipped with warming mechanisms, and
monitoring devices. Additionally, incubators can be isolated if need be for the fragile preterm or
seriously ill neonate. In the studies reviewed, standard IC involves placing the neonate prone in
the incubator surrounded or “nested” in blankets at incline of 30-45°.1 When oral glucose (OG) is
implemented for analgesia, the neonate is administered oral sugar solution prior to the painful
stimulus in addition to being placed per standard IC measures. Caregiver-neonate interaction is
limited with the use of IC, due to the inherent isolation of the incubator module. This interaction
is further minimized during procedures as incubators are often limited to designated areas of the
healthcare facility, and workable space comes at a premium in most nursery settings.
With the conception of Kangaroo Care (“Skin to Skin Contact”) the neonate and
caregiver are in direct physical contact with each other, thus allowing for the comfort,
familiarity, and scent of the caregiver to soothe the neonate whilst the procedure is being
performed. Kangaroo Care (KC) is a nonpharmacologic intervention being used in some medical
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settings to allay neonate pain and distress during minor invasive procedures. The KC procedure
involves placing an undressed, diapered infant upon the mother’s bare chest “skin to skin” as she
sits comfortably at a 45-60° angle.1,2,3 The neonate’s back is covered with a blanket, and the
mother holds the child in position with a firm grip. For the studies, the caregiver is to remain in
this position with the neonate undisturbed for the duration of the intervention period. Other
parent-child interaction is discouraged and outside stimulus is minimized throughout the study
period.
Pain inflicted from procedures such as heel sticks-for blood glucose checks and the
newborn screening, and vitamin K injections are some of the first invasive procedures
experienced by term and preterm neonates in the hospital setting. Both healthy and ill neonates
undergo a number of these tests in the first few hours and days of life. Preterm and ill neonates
may experience an exponentially greater number of such procedures. Evidence shows that
repeated painful stimuli can provoke physiologic and hormonal changes thus affecting the
neurobiology and CNS development of the neonate.1 Moreover, research demonstrates that
preterm infants may lack the pain inhibition abilities of their full term cohorts, leaving them
more sensitive to pain and at greater risk for developing maladaptive pain responses.1,3
If proven effective, Kangaroo Care offers a promising new intervention to decrease
neonate procedural pain. KC affords many advantages over other interventions. It is cost
effective, requiring little to no additional overhead. KC can be utilized in any setting that serves
neonates; such that hospitals, clinics, ERs and Urgent Care facilities may benefit from its use. As
a nonpharmacologic intervention, midlevel providers such as Physician Assistants and Nurse
Practitioners as well as other designated medical staff may initiate KC without requiring a
Physician’s signature. Availability and ability of the caregiver and neonate are essentially

the only prerequisites needed for implementation of the KC intervention.
Objective
The objective of this systematic review is to determine whether or not, “Is Kangaroo Care
effective in reducing procedural pain in neonates?” Previous research has concluded that KC is
effective for promoting preterm neonate development, including thermoregulation and
respiratory maturation. Other randomized, controlled trials have shown promising results using
KC in other avenues of neonate care. However, limited studies are available on the effectiveness
of KC in alleviating neonate pain during routine invasive medical procedures.
Methods
For this review, the author performed a detailed search of the Cochrane, Ovid and
Medline Databases for Randomized Controlled-Trials and Systematic Reviews. Search criteria
included English language, peer reviewed journal articles published from 2005 to present. Key
search terms used: “Kangaroo Care,” “Skin to skin contact,” “pain,” “infant,” and “neonate.” Of
those RCTs selected, the subject population included both term and preterm neonates undergoing
routine minimally invasive medical procedures. Articles chosen were based on relevance and
validity to the objective in question.
The studies selected for this review were all randomized, controlled trials with measures
based on patient oriented outcomes (POEMs). Two of the selected studies compared KC with
IC.2,3 A third study compared these and oral glucose (OG) as analgesia as well.1 Two of the
studies enrolled preterm neonates with 28-36 weeks and 30-32 weeks gestational age
respectively.1,3 In contrast, the Kashaninia group studied full term neonates > 37 weeks
gestational age. The painful stimulus experienced by study subjects was either routine heel stick
or intramuscular vitamin K injection.1,3,2 Studies excluded from this review were those that
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involved KC in subjects older than neonate age, or those undergoing medical procedures where
piercing of the skin was not involved. Demographics of the studies included in this review can be
found in Table 1. All three studies utilized standardized tools for measuring neonate
pain/distress. The statistics used in each study are somewhat variable, with results performed by
ANOVA and Kruskal-Wallis testing; all studies include p-values.
Table 1: Demographics of reviewed studies
Study

Type

# of
Pts

Age

Inclusion
Criteria

Exclusion
Criteria

W/D

Interventions

Freire,
Brazil, 2008

RCT,
Singleblind

105

Preterm
28-36 wks
GA

Healthy
neonates,
Healthy
mothers

Congenital anomalies,
Maternal drug use,
Ventilation
support,
Intraventricular
hemorrhage
Chest drain,
Tracheotomy, Oxygen
therapy,
Hemodynamic
instability,
Analgesia/sedative
care within 48 hours

10

Incubator care
without
analgesia,
Glucose as
analgesia,
Kangaroo
care-10 mins
prior and
during
procedure

Kostandy,
USA,
2008

RCT,
Prospective
cross-over

10

Preterm
30-32 wks
GA;
post-natal
age of
2-9 days

Healthy
neonates,
Healthy
Englishspeaking
mothers,
NPO or
bolus fed
over 20
mins

Congenital anomalies,
Maternal drug use,
Intraventricular
hemorrhage,
Surgical history,
Heel inflammation,
Sedative or analgesia
treatment within 24
hours

0

Kashaninia,
Iran, 2008

RCT,
Gendermatched

100

Full term
37 wks
GA,
Approx 2
hr postnatal age

2500-4000g
at birth,
APGAR >7
at 1 min old,
HR 100-160
bpm,
pO2 > 95%,
Unfed

Congenital anomalies,
Maternal drug use
Caesarean birth,
Administration of any
injection of vaccine,
Birth trauma

0

Incubator care30 mins
undisturbed,
then
procedure,
then 20 min
recovery,
Kangaroo
care-kept in
position 30
mins prior,
during and 20
mins after
procedure
Incubator quiet
time,
Kangaroo care,
both for 10
mins prior to
procedure
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Outcomes Measured
Outcomes measured were based on importance to the patient, and in this case the
caregiver as well. The outcomes measured include expressive cues of neonate pain/distress that
could be easily read by the caregiver and/or hospital staff. All studies used for the review utilized
standardized tools for recognizing and scoring infant pain and distress. One study employed the
Neonatal Infant Pain Score (NIPS) to account for infant facial expression, crying indicators, and
to compile a cumulative score.2 The Andersen Behavioral State Scoring System (ABSSS), which
calculates both audible and inaudible crying times from relevant facial cues, neonate level of
arousal and activity was used by another.3 The third research group utilized the Premature Infant
Pain Profile (PIPP) scoring model to measure eye squeeze, brow bulge, and nasolabial furrowing
as signs of neonatal pain.1 All studies used videotaping and blinded raters for scoring.
Results
Each of the studies presented in this review are randomized, controlled trials with the
intention to treat pain experienced by neonates during routine medical procedures. Two of three
studies compared Kangaroo Care with standard Incubator Care, while the third also compared
oral glucose as an intervention.2,3,1 The Kashaninia group utilized intramuscular vitamin K
injection as the painful stimulus, while both of the other studies used heel stick procedures.1,3
The Freire et al study began with the most participants at 105, but lost 10 due to blinding errors.
Thus the Kashaninia et al study completed with the largest study population at 100. As a pilot
study, the Kostandy et al population was limited to 10 subjects. This group also experienced
blinding errors as one neonate subject was noncompliant to study conditions.
All studies reviewed here utilize standardized tools for measuring neonate distress. Such
measures include the NIPS, ABSSS, and PIPP scoring systems. Although each tool measures
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slightly different signs of distress, overlap did occur and such indicators included audible crying
times and facial cues like brow bulge, grimacing expression, and eye squeeze.1,2,3 All data
presented amongst the studies is continuous. Only the scales used by the Kashaninia group were
convertible to dichotomous data for purposes of this review.
Kashaninia et al utilized the NIPS scoring system for infant pain and distress. Cumulative
NIPS scoring was tiered and assessed values:
No to Mild pain (0-2), Moderate pain (3-4), Severe pain (> 4)
For purposes of this review, scores of no to mild pain (0-2) constituted successful interventions
whereas scores of moderate to severe pain (>3) were considered failures. As such, 62% of the
KC intervention group experienced no to mild pain, while only 2% of the IC control group
scored similarly. Of the 38% of the KC group scoring at a 3 or above only 6% demonstrated
indicators of severe pain. Of those in the 98% of IC group failures, 60% scored a 4 or above
indicating severe pain. P-values for all of the statistics as presented in this research indicated
statistical significance (p < 0.001). Table 2 highlights the clinical significance and treatment
benefit of using KC as compared to IC as presented by Kashaninia et al.
Table 2: Analysis of NIPS Score Outcomes Immediately after Intramuscular Injection
Measured Response

ABI

NNT

p-value

1.136

0.50

+2

p < 0.001

Facial Expression

15.667

0.47

+3

p < 0.001

Cumulative NIPS score

30.000

0.60

+2*

p < 0.001

Cry Response

RBI

RBI=Relative benefit increase, ABI=Absolute benefit increase, NNT=Number needed to treat.
*Based on the cumulative NIPS score analysis the practitioner would need to treat 2 neonates
with KC to reduce pain in 1 neonate during IM injection of vitamin K.
The Kostandy group implemented a randomized cross-over study design utilizing either
KC or IC as the day 1 intervention and switching to the contrary intervention on day 2. The
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ABSS system was used for measuring neonate distress across four phases for each condition on
each day. The phases were continuous from 1) baseline, 2) heel warming, 3) heel stick, and 4)
recovery. The mean total of audible and inaudible crying time was recorded for each subject.
Inaudible crying times were minimal throughout each phase, from 0-1.34 seconds across both
groups on both days. A distinct pattern of crying time emerged in that crying was minimal during
baseline warming, increased during the heel stick procedure, and then declined during the
recovery phase on both days of the study regardless of the intervention used. ANOVA testing
was performed and the results are listed in Table 3.
Table 3: Efficacy of Kangaroo Care in Decreasing Mean Crying Time
Kangaroo
Mean Crying
Time (sec)
5.83

Care
SD

Incubator
Mean Crying
Time (sec)
25.50

7.63
Day 1
Recovery phase
55.00
55.53 96.17
Day 2
Heel stick phase
NR
NR
NR
Days 1 &2
(combined
across phases)
NR=Not Recorded; SD=Standard Deviation

Care
SD

p-value

41.93

ANOVA
F score
NR

92.42

F (1,8) = 7.76

p = 0.001

NR

F (1,8) = 10.25

p < 0.001

NR

Kostandy et al report that differences were minimal between groups during the baseline
and warming phases. In contrast, considerable differences were discovered during the heel stick
and recovery phases, with the day 2 heel stick phase showing the most significant difference in
crying time between groups [F (1,8) = 7.76; p = 0.001]. The KC intervention neonates
experienced significantly less crying time during heel stick than the IC group. The ANOVA
results show a significant difference in combined crying time between phases on both days
[F (1,8) = 10.25; p < 0.001].
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Freire et al compared three interventions for reduction of heel stick pain in neonates: IC,
KC, and OG. Those subjects randomized to the OG group were administered 1 mL of oral
glucose solution by syringe 2 seconds prior to heel stick, and were otherwise placed prone at a
30-45° incline similar to those in the IC group. Behavioral indicators were measured for 30
seconds following the painful stimulus using the PIPP scoring model. These parameters included
brow bulge, eye squeeze, and nasolabial furrowing.
Kruskal-Wallis statistical tests were performed on each parameter. A significant
difference was seen across parameters between groups, with a smaller difference observed
between KC and OG groups as compared to the IC group. Moreover, scores were significantly
lower in the KC group than either of the other two groups. An abbreviated listing of the results is
provided in Table 4. ANOVA tests were also performed in this study for physiologic measures of
heart rate and oxygen saturation (p-value < 0.05). However, as these outcomes are difficult to
assess by non-medical personnel (i.e. an untrained caregiver), these statistics were excluded from
this review.
Table 4: Abbreviated Summary of Behavioral Indicators before and after painful stimulus
Facial Cue

Kangaroo
Care (n=31)
0.96 + 0.87

Oral Glucose
(n=31)
1.48 + 0.92

p-value

Brow Bulge

Incubator
Control (n=33)
2.33 + 0.64

Eye Squeeze

1.75 + 0.79

0.54 + 0.88

1.06 + 0.81

0.0001

Nasolabial Furrowing

1.75 + 0.75

0.48 + 0.85

1.00 + 0.81

0.0001

0.0001

All results listed as mean + SD
Discussion
Across all three studies reviewed, Kangaroo Care does appear to be more effective than
standard incubator care in treating neonate pain due to minimally invasive procedures. Audible
crying times were less in the KC groups versus the IC groups across all studies. Results in the
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cross-over study were most profound during heel stick and recovery phases and more so on day 2
of the interventions.2 It should also be noted that no adverse events were reported with any of the
interventions used.
All studies reviewed here encountered limitations. As a pilot study, Kostandy et al had a
sample population much too small to establish any correlations. Also, within this study it states
that “80% of subjects had previous KC experience.”3 Having a sample population with previous
exposure to the intervention in question may skew the results of the current research and must be
accounted for. The Freire study was also troublesome, as information on enrollment methods and
inclusion criteria was somewhat limited.
All studies had issues with blinding. This caused the majority of withdrawals accounted
for in this review. Videotaping was used to assist in rating the NIPS, ABSSS, and PIPP
measures. Due to the nature of the KC intervention, only single-blindedness could be achieved.
This too was limited as some neonates did move during taping and response rating issues arose.
Another limitation in regard to rating, involved those actually scoring the responses. Only one
study utilized a multiple rater system and determined inter-rater reliability to score each subject
for data purposes.2 Both of the other studies used a single rater, and did not account for any bias
that may have occurred from this practice.
The optimal amount of time for KC to be effective in reducing neonate pain remains to be
determined. Of the three studies reviewed, the KC intervention was initiated from 10 to 30
minutes prior to the painful stimulus, and continued from 0 to 20 minutes post-procedure.1,3,2
Yet, concomitant outcome responses were measured and scored for periods as short as 30
seconds post-procedure.1 Such a disparity between time frames provokes inquiry as to whether
the post-procedure follow up and scoring should be based on a longer review period.
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Strengths of the studies were multiple. The Kashaninia group effectively performed a
randomized gender-matched trial with a solid population size. The use of standardized measures
for scoring neonate pain and distress were well conceived. Kostandy et al benefited from using
the ABSS system as it measures both audible and inaudible cry times.
Kangaroo Care shows promise as a nonpharmacologic intervention for use in treating
neonate pain and distress during routine minimally invasive medical procedures. It requires low
to no overhead costs to implement. It can be initiated by healthcare providers at multiple levels
without a physician’s authorization. The requirements to carry out the intervention are minimal,
and depend on the ability and availability of the neonate and caregiver involved.
Conclusion
The studies reviewed demonstrate that Kangaroo Care is effective in reducing procedural
pain in neonates; and that it is more effective than standard incubator care in doing so. Further
research should focus on specific painful procedures and optimal periods of KC as intervention.
KC research should be expanded to include similar medical procedures in those infants beyond
neonate age, say up to 12 months old. Likewise, research should also be conducted with KC and
the paternal caregiver and/or a designated surrogate. Modern family situations are complex,
maternal caregivers may fall ill or die from complications of labor and delivery; yet Kangaroo
Care offers an intervention with potentially few limitations. As long as a willing bonding partner
is available to the neonate, and that partner is comfortable and able to perform the procedure, it is
expected to be successful. The neonate will sense stress from the bonding partner whether
mother, father or surrogate if that partner is anxious about the intervention. Perhaps, further
researchers should also survey the caregiver to assess his/her level of anxiety about participating
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in the Kangaroo Care intervention and about observing the neonate in pain. It is inherent for
many caregivers to be distressed from anticipating or observing one’s child in pain.
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